A detailed history of Eventide Asset Management, LLC transactions in Guardant Health, Inc. stock. As of the latest transaction made, Eventide Asset Management, LLC holds 3,837,300 shares of GH stock, worth $119 Million. This represents 1.55% of its overall portfolio holdings.

Number of Shares
3,837,300
Previous 3,760,538 2.04%
Holding current value
$119 Million
Previous $109 Million 18.98%
% of portfolio
1.55%
Previous 1.91%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$22.3 - $36.29 $1.71 Million - $2.79 Million
76,762 Added 2.04%
3,837,300 $88 Million
Q2 2024

Aug 13, 2024

SELL
$16.07 - $31.84 $6.73 Million - $13.3 Million
-418,894 Reduced 10.02%
3,760,538 $109 Million
Q1 2024

May 15, 2024

BUY
$17.13 - $26.91 $4.99 Million - $7.84 Million
291,286 Added 7.49%
4,179,432 $86.2 Million
Q4 2023

Feb 14, 2024

BUY
$21.58 - $29.5 $6.44 Million - $8.81 Million
298,616 Added 8.32%
3,888,146 $105 Million
Q3 2023

Nov 14, 2023

SELL
$25.8 - $39.97 $10.8 Million - $16.8 Million
-419,072 Reduced 10.45%
3,589,530 $106 Million
Q2 2023

Aug 15, 2023

BUY
$20.94 - $38.01 $44.7 Million - $81.1 Million
2,133,582 Added 113.79%
4,008,602 $144 Million
Q1 2023

May 15, 2023

BUY
$22.92 - $33.76 $4.45 Million - $6.55 Million
194,020 Added 11.54%
1,875,020 $44 Million
Q2 2022

Aug 15, 2022

BUY
$28.82 - $77.35 $10.6 Million - $28.5 Million
368,100 Added 28.04%
1,681,000 $67.8 Million
Q1 2022

May 16, 2022

BUY
$48.25 - $100.49 $20.6 Million - $42.9 Million
426,800 Added 48.17%
1,312,900 $87 Million
Q4 2021

Feb 14, 2022

BUY
$88.71 - $120.43 $62.8 Million - $85.3 Million
708,100 Added 397.81%
886,100 $88.6 Million
Q3 2021

Nov 15, 2021

BUY
$98.77 - $132.17 $17.6 Million - $23.5 Million
178,000 New
178,000 $22.3 Million

Others Institutions Holding GH

About Guardant Health, Inc.


  • Ticker GH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,220,000
  • Market Cap $3.17B
  • Description
  • Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...
More about GH
Track This Portfolio

Track Eventide Asset Management, LLC Portfolio

Follow Eventide Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eventide Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eventide Asset Management, LLC with notifications on news.